Hi Gujarat
Menu
  • Home
  • Business
  • Lifestyle
  • Health
  • Education
  • National
  • PR
Menu

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

Posted on July 21, 2021 by dsprime

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.

As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.

“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.

Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.

Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

Leave a Reply Cancel reply

Your email address will not be published.

Recent Posts

  • Black Bunny launches the largest BB Club and Game Zone to provide endless fun and a healthy lifestyle to the people of Surat
  • VABB- A non-invasive advanced technique to remove benign breast lumps
  • Zenith Coworking Space launches its centre in Raipur, Chhattisgarh. Hits 100% booking even before launch
  • Online hiring & engagement platform Dare2Compete rebrands to Unstop!
  • Future of Loyalty Rewards with real crypto currency (Blockchain Technology)

Recent Comments

  • ankara sincan nakliye on The Incredible Journey of ‘Man of Exports’-Bhagirath Goswami
  • Hcyhaj on First-Hand Experience of CM Yogi’s Leadership in COVID Management would help handle intense 2nd COVID wave in UP: State Health Minister
  • Dlalaemurnejr on greytHR makes place in G2’s Best Software List
  • Oxqask on Effective April 1, 2021: itelligence | NTT DATA Business Solutions will operate as NTT DATA Business Solutions
  • cứu tôi on Prime Minister Modi appreciates Barwani startup Farmkart

Archives

  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020

Categories

  • A
  • Business
  • Design
  • Education
  • English
  • Entertainment
  • Health
  • Hindi
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
  • एजुकेशन
  • नेशनल
  • बिज़नस
  • लाइफस्टाइल
  • हेल्थ

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
©2022 Hi Gujarat | WordPress Theme by Superbthemes.com